跳至主要内容
临床试验/IRCT20210216050373N4
IRCT20210216050373N4尚未招募1 期

Evaluation of safety and efficiency of curcumin in the immune system and viral load of patient with HIV

Tehran University of Medical Sciences0 个研究点目标入组 100 人开始时间: 待定最近更新:

试验速览

阶段
1 期
状态
尚未招募
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 no limit(—)
性别
All

入选标准

  • people with positive test ( PCR)
  • people with positive test ( Elisa)

排除标准

  • Patient with hepatitis B
  • Patient with hepatitis C
  • Breastfeeding
  • Alcohol and Drug use
  • Use of Growth Hormone (at least 30 days before the study)
  • Use of Immunosuppressive drugs
  • Use of Testosterone and Anabolic Steroids (at least 30 days before the study)
  • Under Chemotherapy with Interferon or Radiotherapy
  • Patients with Undetectable viral loads

研究者

相似试验